At a Glance: Departmental Evaluation Plan for the Public Health Agency of Canada, 2022-23 to 2026-27
The OAE Departmental Evaluation Plan for PHAC describes the Program Evaluation Division’s scheduled work for the five-year period from 2022-23 to 2026-27. The Plan was developed to meet PHAC’s commitments under the Policy on Results (2016) which requires that each department prepare a five-year plan, updated annually.
The projects included in this Evaluation Plan were selected to ensure full coverage of all Grant and Contribution spending over $5 million annually over a five-year period, prior commitments in Treasury Board Submissions, the information needs of program management, program risks, and optimal use of resources. The Departmental Results Framework (DRF), program inventory, and performance information profiles developed by PHAC have formed the basis for this plan.
The COVID-19 pandemic continues to have a significant impact on the work of the Public Health Agency of Canada (PHAC) as it remains at the forefront of the Government of Canada’s response. The present Departmental Evaluation Plan (DEP) reflects the response of the Office of Audit and Evaluation (OAE) to these circumstances, as it is a plan that ensures that OAE focuses its efforts and resources on emerging priorities while continuing to meet our reporting commitments under the Financial Administration Act (FAA). In addition, the impact of COVID-19 on PHAC’s activities will be looked at as part of program activities in various evaluations contained in the DEP (e.g., Border and Travel Health, Emergency Preparedness and Response, Immunization and Respiratory Diseases).
Planning for Evaluation
Over the next five years, OAE plans to conduct 33 evaluations that involve PHAC: 24 will focus exclusively on PHAC activities and two will examine the activities of both PHAC and Health Canada. The remaining seven projects are horizontal evaluations led by other government departments or agencies. A yearly breakdown is provided in Table 1. Table 2 outlines the direct program spending (DPS) by core responsibility for all scheduled evaluations for the next five years.
| 2022-23 | 2023-24 | 2024-25 | 2025-26 | 2026-27 | Total | |
|---|---|---|---|---|---|---|
| PHAC | 4 | 4 | 6 | 7 | 3 | 24 |
| PHAC and HC | 1 | 0 | 0 | 1 | 0 | 2 |
| Horizontal (OGD-led) | 3 | 1 | 1 | 1 | 1 | 7 |
| Total | 8 | 5 | 7 | 9 | 4 | 33 |
| Program | Evaluations planned in the next five years | Fiscal year of approval | 2022-23 spending covered by evaluation ($)Footnote 1 | Rationale for not evaluating program or spending |
|---|---|---|---|---|
| Core Responsibility | Health Promotion and Chronic Disease Prevention ($395,463,352) | |||
| Health Promotion
($214,751,791) |
Action Plan for Official Languages 2018-2023: Investing in Our Future | 2022-23 | $2,108,475 | |
| Autism Spectrum Disorder Initiatives | 2022-23 | $5,423,348 | ||
| Indigenous Early Learning and Child Care Initiative | 2023-24 | $27,215,415 | ||
| Aging and Seniors | 2023-24 | $19,354,208 | ||
| PHAC’s Mental Health Activities – Pan-Canadian Suicide Prevention Service | 2024-25 | $4,693,007 | ||
| Preventing and Addressing Family Violence: the Health Perspective | 2024-25 | $6,250,000 | ||
| PHAC'S Mental Health Activities - Mental Health Promotion Innovation Fund | 2024-25 | $4,947,000 | ||
| Nutrition North Canada | 2024-25 | $335,000 | ||
| Maternal and Child Health Programs | 2025-26 | $97,593,695 | ||
| Aboriginal Head Start in Urban and Northern Communities | N/A | $33,347,831 | Delayed from 2021-22, now scheduled for completion in 2022-23, and the next scheduled evaluation will be in 2027-28. | |
| Preventing Gender-Based Violence: the Health Perspective (formerly Supporting the Health of Survivors of Family Violence) | N/A | $13,483,812 | This is a horizontal evaluation led by WAGE, the timing of which will be determined in a future Departmental Evaluation Plan. | |
| Chronic Disease Prevention
($34,563,854) |
ParticipACTION | 2023-24 | $5,000,000 | |
| Healthy Canadians and Communities Fund | 2025-26 | $27,640,555 | ||
| Health Portfolio's Tobacco and Vaping Activities | 2025-26 | $205,000 | ||
| Office of International Affairs | 2025-26 | $0 | ||
| Development of a National Diabetes Framework | N/A | $1,718,299 | The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan. | |
| Evidence for Health Promotion, and Chronic Disease and Injury Prevention
($146,147,707) |
Horizontal Evaluation of the Legalization and Regulation of Cannabis | 2022-23 | $0 | |
| Canadian Drug and Substance Strategy (Including opioids and drug overdose crisis in Canada) | 2022-23 | $1,545,658 | ||
| Fetal Alcohol Spectrum Disorder (FASD) Initiatives | 2022-23 | $1,499,000 | ||
| Autism Spectrum Disorder Initiatives | 2022-23 | $786,834 | ||
| Canadian Task Force on Preventive Health Care | 2022-23 | $0 | ||
| Aging and Seniors | 2023-24 | $2,985,464 | ||
| National Collaborating Centres | 2023-24 | $2,921,002 | ||
| PHAC’s Mental Health Activities - Pan-Canadian Suicide Prevention Service | 2024-25 | $94,219 | ||
| Nutrition North Canada | 2024-25 | $50,000 | ||
| Healthy Canadians and Communities Fund | 2024-25 | $1,333,000 | ||
| PHAC's Mental Health Activities – includes Supporting Mental Health of those Most Affected by COVID-19 | 2024-25 | $94,115,668 | ||
| Evidence for Health Promotion Chronic Disease and Injury Prevention (including CPHO Report, CCDR) | 2026-27 | $40,007,492 | ||
| Office of the Chief Dental Officer | 2026-27 | $567,827 | ||
| Preventing Gender-Based Violence: the Health Perspective (formerly Supporting the Health of Survivors of Family Violence) | N/A | $241,543 | This is a horizontal evaluation led by WAGE, the timing of which will be determined in a future Departmental Evaluation Plan. | |
| Core Responsibility | Infectious Diseases Prevention and Control ($7,404,958,375) | |||
| Laboratory Science Leadership and Services
($430,092,190) |
Food-borne and Water-borne Enteric Diseases | 2022-23 | $1,921,568 | |
| Sexually Transmitted and Blood-Borne Infections | 2023-24 | $6,225,772 | ||
| Immunization and Respiratory Infectious Diseases | 2024-25 | $2,401,103 | ||
| Emergency Preparedness and Response | 2024-25 | $16,261,242 | ||
| Genomics Research and Development Initiative (GRDI) | 2025-26 | $2,339,465 | ||
| Infectious Disease and Climate Change | 2025-26 | $1,116,689 | ||
| Border and Travel Health Program | 2025-26 | $354,758,273 | ||
| Adapting to Impacts of Climate Change (Roll-up of Departmental Evaluation) | 2026-27 | $0 | ||
| Medical Countermeasures Capacity | N/A | $45,068,078 | The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan. | |
| Communicable Diseases and Infection Control
($1,245,315,549) |
Canadian Drug and Substance Strategy (Including opioids and drug overdose crisis in Canada) | 2022-23 | $7,000,000 | |
| Blood Safety (Canadian Blood Services Contribution Programs and PHAC Blood Safety Program) | 2022-23 | $2,150,000 | ||
| Autism Spectrum Disorder Initiatives | 2022-23 | $264,056 | ||
| Sexually Transmitted and Blood-Borne Infections | 2023-24 | $29,599,000 | ||
| National Collaborating Centres | 2023-24 | $973,666 | ||
| Health Care-Associated Infections | 2024-25 | $3,884,131 | ||
| Emergency Preparedness and Response | 2024-25 | $151,444,696 | ||
| Office of International Affairs | 2025-26 | $0 | ||
| Tuberculosis | 2026-27 | $0 | ||
| Therapeutics | N/A | $1,050,000,000 | The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan. | |
| Vaccination
($5,707,095,413) |
Immunization and Respiratory Infectious Diseases | 2024-25 | $5,651,502,565 | |
| Sero-Surveillance Research Program | 2024-25 | $55,592,848 | ||
| Foodborne and Zoonotic Disease
($22,455,223) |
Food-borne and Water-borne Enteric Diseases | 2022-23 | $3,626,301 | |
| National Collaborating Centres | 2023-24 | $973,666 | ||
| Emergency Preparedness and Response | 2024-25 | $12,789,552 | ||
| Office of International Affairs | 2025-26 | $0 | ||
| Infectious Disease and Climate Change | 2025-26 | $4,998,394 | ||
| Genomics Research and Development Initiative (GRDI) | 2025-26 | $67,310 | ||
| Adapting to Impacts of Climate Change (Roll-up of Departmental Evaluation) | 2026-27 | $0 | ||
| Core Responsibility | Health Security ($420,058,672) | |||
| Emergency Preparedness and Response
($337,782,630) |
Food-borne and Water-borne Enteric Diseases | 2022-23 | $87,171 | |
| National Collaborating Centres | 2023-24 | $973,666 | ||
| Emergency Preparedness and Response | 2024-25 | $336,402,170 | ||
| Biosecurity Program | 2025-26 | $319,623 | ||
| Biosecurity
($11,885,712) |
Healthy Canadians and Communities Fund | 2024-25 | $75,000 | |
| Biosecurity Program | 2025-26 | $11,810,712 | ||
| Border Health Security
($70,390,330) |
Border and Travel Health Program | 2025-26 | $70,299,791 | |
| Biosecurity Program | 2025-26 | $90,539 | ||
| Core Responsibility | N/A ($4,700,000) | |||
| Internal Services
($4,700,000) |
National Collaborating Centres | 2023-24 | $3,200,000 | |
| Pan-Canadian Health Data Strategy | 2025-26 | $0 | ||
| Optimizing External Evidence on Complex Scientific Public Health Issues | N/A | $1,500,000 | The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan. | |
Footnotes
|
||||
Page details
- Date modified: